Here are four things to know, according to a Feb. 17 news release:
1. Abridge, which offers a mobile app for providers that ambiently listens to medical appointments and drafts clinical notes for the EHR, received the series D funding Feb. 17 co-led by investor Elad Gil and venture capital firm IVP.
2. The company also surpassed 100 health system deployments, including new clients Akron (Ohio) Children’s, Evanston, Ill.-based Endeavor Health, Fairfax, Va.-based Inova Health System and New York City-based Memorial Sloan Kettering Cancer Center. “The quality of specialty-specific notes and Abridge’s responsiveness to clinician feedback with rigorously tested enhancements stood out to us,” stated Matt Kull, executive vice president and chief information and digital officer at Inova.
3. Abridge also introduced a contextual reasoning engine, which it described as “an AI architecture that produces more clinically useful and billable notes at the point of care.”
4. Other notable investors in the $250 million funding round included CVS Health Ventures, Alphabet growth fund CapitalG and NVentures, the venture capital arm of AI giant Nvidia.
